Episomal BK virus (BKV) DNA was detected in primary human brain tumours, in Kaposi's sarcoma and in cell lines from brain tumours, Ewing sarcoma and osteogenic sarcoma. Infectious BKV was rescued from several tumours and tumour cell lines by transfection of total cellular DNA into human embryonic fibroblasts. Restriction endonuclease and nucleotide sequence analysis showed that all the rescued viruses are similar to BKV-IR, a BK variant previously isolated from a human tumour of pancreatic islets, indicating that a specific BKV strain may be associated with certain types of human tumours. All the variants contain a putative transposable element in the regulatory region of the viral genome. This region has mutagenic properties and enhancing activity in transformation, suggesting a possible role of these variants in tumour induction or progression.
BK virus (BKV) is a human papovavirus with a general distribution in the normal population world-wide (Gardner, 1973; Shah et al., 1973; Portotani et al., 1974; Brown et al., 1975) . Primary infection occurs in childhood, after which BKV remains latent in the kidney and tonsils (Heritage et al., 1981; Chesters et al., 1983; Grinnell et al., 1983; Goudsmit et al., 1982) . BKVinduced acute diseases in immunocompetent individuals affect mainly the upper respiratory apparatus (Goudsmit et al., 1981 (Goudsmit et al., , 1982 and the urinary tract (Hashida et al., 1976; Mininberg et al., 1982) . In immunodeficient or immunosuppressed hosts, BKV latent infection is reactivated (Andrews et al., 1988) and produces lesions in the urinary apparatus (Coleman et al., 1978) , the most severe of which is haemorrhagic cystitis in bone marrow transplant recipients (Arthur et al., 1988) .
BKV transforms rodent, monkey and human cells (Portolani et al., 1975 (Portolani et al., , 1978 Purchio & Fareed, 1979; Takemoto et al., 1979; Grossi et al., 1982) and is oncogenic in hamsters, mice and rats. Tumours induced in experimental animals include brain tumours, tumours of pancreatic islets, osteosarcomas and fibrosarcomas (Corallini et al., 1977 Costa et al., 1976; Uchida et al., 1976 Uchida et al., , 1979 . In agreement with the indications of this experimental pathogenicity, BKV DNA was detected by Southern blot hybridization in human brain tumours and tumours of pancreatic islets (Corallini et al., 1987; D6rries et al., 1987) .
Because of the relationship of Kaposi's sarcoma (KS) with immunosuppression, we have investigated tissue from classical and African KS for the presence of BKV DNA. In addition, we have analysed a number of cell lines derived from brain tumours and sarcomas. Agarose gel electrophoresis and nucleic acid hybridization were carried out according to Southern (1975) . BKV DNA probes were labelled by primer extension (Feinberg & Vogelstein, 1984) . Nucleotide sequence analysis was performed by the dideoxynucleotide chain-terminating method (Sanger et al., 1977) . Mutagenesis of the hypoxanthine-guanine phosphoribosyltransferase (HGPRT) locus was carried out according to the method of Brandt et al. (1987) . To construct the recombinant DNA molecules, standard procedures were followed (Maniatis et al., 1982) . Primary mouse embryo fibroblasts and Rat-1 cells were grown and propagated in Dulbecco's modified Eagle's minimum essential medium supplemented with 10~ foetal bovine serum.
The results presented in Table I show that BKV DNA is associated with African KS, ependymoma, meningioma, glioblastoma, glioma, neuroblastoma, Ewing sarcoma and osteogenic sarcoma. Control human tumour cell lines from epithelioma (Hep-2), hepatoma (HepG2) and cervical carcinoma (KNC) were negative. BKV DNA was free in tumour cells (Fig. 1 ) and only in rare tumours were viral sequences integrated into cellular DNA. Infectious BKV was rescued from several positive 0000-9635 © 1990 SGM F i l l t u m o u r s a n d t u m o u r cell lines by t r a n s f e c t i o n of h u m a n e m b r y o n i c fibroblasts with total cellular D N A (Table 1) .
T h e rescued viruses have the a n t i g e n i c a n d biological properties of wild-type B K V . T h e y t r a n s f o r m p r i m a r y m o u s e e m b r y o cells a n d i n d u c e e p e n d y m o m a s u p o n i n t r a c e r e b r a l i n o c u l a t i o n in n e w b o r n h a m s t e r s (Table 2) . T r a n s f o r m i n g activity a revealed that ependymomas induced by variants BKV-E, BKV-KS85 and BKV-KS122 have a higher number of malignancy markers than BKV-WT-induced tumours since they show more atypic cells, more frequent mitoses, invasiveness and microscopic metastases in the subarachnoidal space (data not shown).
The genomic DNA of all the rescued viruses, analysed by agarose gel electrophoresis after digestion with several restriction endonucleases, has the same restriction pattern. Fig. 2 shows a representative result obtained with the two variants rescued from KS. The large PvulI fragment migrates faster than in BKV-WT. The KS variants have lost one BgllI site and produce only three HindlII fragments instead of four since HindlII fragment D is missing. In addition HindlII fragments B and C are larger than the corresponding wild-type fragments and linear EcoRI-digested molecules migrate slightly faster than BKV-WT DNA. This restriction pattern is similar to that of BKV-IR (Fig. 2) , a BKV variant rescued from a human tumour of pancreatic islets (Caputo et al., 1983; Pagnani et al., 1986) and is compatible with an insertion into the regulatory region of the viral genome, which is in HindlII fragment C, as well as with a deletion around map unit 0.54 where a BgllI site and the HindlII site between fragments B and D are located.
Nucleotide sequence analysis established that the insertion and the deletion are similar in BKV-IR and in the rescued variants, differing in only a few nucleotides in the insertion (Fig. 3) . The deletion, in different variants, is due to a loss of 253 bp between nucleotides 2792 and 3044. No rearrangements are observed in the regions flanking the deletion, where the nucleotide sequence is collinear with that of BKV-WT DNA (data not shown). The deleted nucleotides remove sequences coding for the middle and carboxy-terminal portions of the small t antigen and contain the donor splice site for the small t antigen 20S mRNA (nucleotides 2792 and 2793) (Yoshiike & Takemoto, 1986) . The deletion falls within the sequence spliced out of the early region primary transcript (nucleotides 2725 to 3069) to yield the 19S mRNA for the large T antigen (Yoshiike & Takemoto, 1986 ) so that expression of the large T antigen is not affected. The insertion is made up of 80 nucleotides distributed in four clusters that produce rearrangements in the region of the enhancer repeats (Fig. 3) . The inserted sequences are flanked by two 12 nucleotide direct repeats flanked by inverted repeats (Fig. 3) so that the whole insertion could fold over to form a putative transposable insertion sequence (IS) (Fig. 4) . If this sequence is a mobile element able to transpose from the viral DNA to the cell genome, it could induce tumours by mutation or by insertional activation of cellular oncogenes. The latter hypothesis is supported by the observation that the IS sequence contains transcriptional enhancers in loop two of the early region (Fig. 4) .
To test these hypotheses, we constructed recombinant DNA molecules containing HindIII fragment C of BKV-IR (pBode-IR) and of BKV-WT (pBode-WT) and compared their mutagenic effect and enhancer activity upon transformation. The plasmid pML-Tet, used to construct pBode-IR and pBode-WT, was a control. Induction of mutation was measured by transfection of recombinants into Rat-1 and CHO cells and selection in medium containing 6-thioguanine (0.1 mM) which allows detection of cells with mutations in the gene coding for HGPRT (Caskey & Kruh, 1979) . The results presented in Table 3 show that the mutation frequency after transfection of pBode-IR is seven times greater than in cells transfected with pBode-WT. Comparable mutation frequencies have been obtained in six individual experiments. Similar IS-like structures, endowed with mutagenic activity, were detected in the transforming region of the genomes of herpes simplex virus type 2 and cytomegalovirus (Galloway et al., 1984; Brandt et al., 1987) . To test the enhancer activity in transformation, BKV-IR or BKV-WT HindlII fragment C were placed upstream of the activated human c-ras oncogene and the recombinants were transfected into Rat-1 cells. As shown in Table 4 , pBode-IR/c-rasA produces a significantly higher number of transformed foci than pBode-WT/c-rasA and pBR/c-rasA which does not contain BKV sequences (Pagnani et aL, 1988 41-2 1-5 x 10 -6 0 * Plating efficiency was calculated as the ratio between the number of colonies and the number of cells plated (2 x 102/10 cm Petri dish) under non-selective conditions. t The mutation frequency (Mr) was calculated by the formula Mf = M/CE, where M is the number of mutants obtained, C is the total number of cells plated (1.5 x 107) and E is the plating efficiency. For each transfection, 30 Petri dishes of 10 cm diameter, each containing 5 x 10 s cells, were prepared as described previously (Brandt et al., 1987) .
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Fig the entire BKV early region cooperates with activated c-ras in the induction of the transformed phenotype (Pagnani et al., 1988) . These experiments show that a specific BKV variant is associated with human brain tumours, osteosarcomas and African KS. This is a more aggressive, systemic form of the tumour, resembling KS in AIDS patients. Because of its ubiquity in the human population, it is possible that BKV is a passenger in these tumours. In addition, the pathogenesis of KS may be related to other viruses, such as cytomegalovirus (Giraldo & Beth, 1986) , to activation of oncogenes or to abnormal production of cytokines and growth factors Salahuddin et al., 1988; Ensoli et al., 1989a, b) . Nevertheless, the physical structure of the putative IS-like sequence present in the regulatory region of BKV variants as well as its mutagenic effect and enhancing activity in transformation are worthy of further investigation in order to determine its possible role in tumour induction or progression.
